Ribozymes. Their Functions and Strategies for Their Use

Applied Biochemistry and Biotechnology - Part B Molecular Biotechnology

Volumn 7, Issue 2, 1997, Pages 125-137

  Gibson, Sandra A ^a   Shillitoe, Edward I ^b  

^a State University of New York Upstate Medical University: College of Medicine   (United States)

^b NONE

Author keywords

Cleavage; Delivery; Expression; Hybridization; Ribozymes; RNA targets

Indexed keywords

RIBOZYME;

ANIMAL; CHEMISTRY; CONFORMATION; GENE EXPRESSION; GENE THERAPY; HUMAN; MOLECULAR GENETICS; NUCLEIC ACID HYBRIDIZATION; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; REVIEW;

ANIMALS; BASE SEQUENCE; GENE EXPRESSION; GENE THERAPY; HUMANS; MOLECULAR SEQUENCE DATA; NUCLEIC ACID CONFORMATION; NUCLEIC ACID HYBRIDIZATION; RNA, CATALYTIC;

EID: 0031114113     PISSN: 10736085     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02761748     Document Type: Review

References (57)

1. Cech, T. R. (1987) The chemistry of self-splicing RNA and RNA enzymes. Science 236, 1532-1539.
2. Forster, A. C., Davies, C., Sheldon, C., Jeffries, A., and Symons, R. (1988) Self-cleaving viroid and newt RNAs may only be active as dimers. Nature 334, 265-267.
3. Haseloff, J. and Gerlach, W. L. (1989) Sequences required for self-catalysed cleavage of the satellite RNA of tobacco ringspot virus. Gene 82, 43-52.
4. Haseloff, J. and Gerlach, W. L. (1988) Simple RNA enzymes with new and highly specific endoribo-nuclease activities. Nature 334, 585-591.
5. Moffat, A. S. (1991) Making Sense of Antisense. Science 253, 510,511.
6. Sarver, N., Cantin, E. M., Chang, P. S., Zai, J. A., Ladne, P. A., Stephens, D. A., and Rossi, J. J. (1990) Ribozymes as potential anti-HIV-1 therapeutic agents. Science 247, 1222-1225.
7. Chen, Z., Kamath, P., Zhang, S., Weil, M. M., and Shillitoe, E. J. (1995) Effectiveness of three ribozymes for cleavage of an RNA transcript from human papillomavirus type 18. Cancer Gene Ther. 2, 263-271.
8. Snyder, D. S., Wu, Y., Wang, J. L., Rossi, J. J., Swiderski, P., Kaplan, B. E., and Forman, S. J. (1993) Ribozyme-mediated inhibition of bcr-abl gene expression in a Philadelphia chromosome-positive cell line. Blood 82, 600-605.
9. Koizumi, M., Hayase, Y., Iwai, S., Kamiya, H., Inoue, H., and Ohtsuka, E. (1989) Design of RNA enzymes distinguishing a single base mutation in RNA. Nucleic Acids Res. 17, 7059-7071
10. Koizumi, M., Kamiya, H., and Ohtsuka, E. (1992) Ribozymes designed to inhibit transformation of NIH3T3 cells by the activated c-Ha-ras gene. Gene 117, 179-184.
11. Cech, T. R., Zaug, A. J., and Grabowski, P. J. (1981) In Vitro splicing of the ribosomal RNA precursor of tetrahymena: involvement of a guanosine nucleotide in the excision of the intervening sequence. Cell 27, 487-496.
12. Kruger, K., Grabowski, P. J., Zaug, A. J., Sands, J., Gottschling, D. E., and Cech, T. R. (1982) Self-splicing RNA: autoexcision and autocyclization of the ribosomal RNA intervening sequence of tetrahymena. Cell 31, 147-157.
13. Cech, T. R. (1988) Ribozymes and their medical implications. JAMA 260, 3030-3034.
14. Guerrier-Takada, C., Gardiner, K., Marsh, T., Pace, N., and Altman, S. (1983) The RNA moiety of ribonuclease P is the catalytic subunit of the enzyme. Cell 35, 849-857.
15. Wu, H.-N., Lin, Y.-J., Lin, F.-P., Makino, S., Chang, M.-F. and Lai, M. C. (1989) Human hepatitis 5 virus RNA subfragments contain an autocleavage activity. Proc. Natl. Acad. Sci. USA 86, 1831-1835.
16. Symons, R. H. (1989) Self-cleavage of RNA in the replication of small pathogens of plants and animals. Trends Biochem. Sci. 14, 445-450.
17. Sheldon, C. C. and Symons, R. H. (1989) RNA stem stability in the formation of a self-cleaving hammerhead structure. Nucleic Acids Res. 17, 5665-5677
18. Shimayama, T., Nishikawa, S., and Taira, K. (1995) Generality of the NUX rule: kinetic analysis of the results of systematic mutations in the trinucleotide at the cleavage site of hammerhead ribozymes. Biochemistry 34, 3649-3654.
19. Zoumadakis, M. and Tabler, M. (1995) Comparative analysis of cleavage rates after systematic permutation of the NUXO consensus target motif for hammerhead ribozymes. Nucleic Acids Res. 23, 1192-1196.
20. Perriman, R., Delves, A., and Gerlach, W. L. (1992) Extended target-site specificity for a hammerhead ribozyme. Gene 113, 157-163.
21. Scarabino, D. and Tocchini-Valentini, G. P. (1996) Influence of substrate structure on cleavage by hammerhead ribozyme. FEBS Lett. 383, 185-190.
22. Ishizaka, M., Ohshima, Y., and Tani, T. (1995) Isolation of active ribozymes from an RNA pool of random sequences using an anchored substrate RNA. Biochem. Biophys. Res. Commun. 214, 403-409.
23. Sheldon, C. C. and Symons, R. H. (1989) Mutagenesis analysis of a self-cleaving RNA. Nucleic Acids Res. 17, 5679-5685.
24. Homann, M., Tabler, M., Tzortzakaki, S., and Sczakiel, G. (1994) Extension of helix II of an HIV-1-directed hammerhead ribozyme with long antisense flanks does not alter kinetic parameters in vitro but causes loss of the inhibitory potential in living cells. Nucleic Acids Res. 22, 3951-3957.
25. Fedor, M. J., and Uhlenbeck, O. C. (1990) Substrate sequence effects on "hammerhead" RNA catalytic efficiency. Proc. Natl. Acad. Sci. USA 87, 1668-1672.
26. Devereux, J., Haeberli, P., and Smithies, O. (1983) A comprehensive set of sequence analysis programs for the VAX. Nucleic Acids Res. 12, 387-395.
27. Lieber, A. and Strauss, M. (1995) Selection of efficient cleavage sites in target RNAs by using a ribozyme expression library. Mol. Cell. Biol. 15, 540-551.
28. Fedor, M. J. and Uhlenbeck, O. C. (1992) Kinetics of intermolecular cleavage by hammerhed ribozymes. Biochemistry 31, 12,042-12,054.
29. Steinecke, P., Steger, G., and Schreier, P. H. (1994) A stable hammerhead structure is not required for endonucleolytic activity of a ribozyme in vivo. Gene 149, 47-54.
30. Crisell, P., Thompson, S., James, W., (1993) Inhibition of HIV-1 replication by ribozymes that show poor activity in vitro. Nucleic Acids Res. 21, 5251-5255.
31. Rittner, K., Burmester, C., and Sczakiel, G. (1993) In vitro selection of fast-hybridizing and effective antisense RNAs directed against the human immunodeficiency virus type 1. Nucleic Acids Res. 21, 1381-1387.
32. Saxena, S., Ackerman, E. (1990) Ribozymes correctly cleave a model substrate and endogenous RNA in vivo. J Biol. Chem. 265, 17,106-17,109.
33. Chen, L., Thomas, E. K., Hu, S. L., Hellstrom, I., and Hellstrom, K. E. (1991) Human papillomavirus type 16 nucleoprotein E7 is a tumor rejection antigen. Proc. Natl. Acad.Sci. USA 88, 110-114.
34. Heidenreich, O. and Eckstein, F. (1992) Hammerhead ribozyme-mediated cleavage of the long terminal repeat RNA of human immunodeficiency virus type 1. J. Biol. Chem. 267, 1904-1909.
35. Beigelman, L., McSwiggen, J. A., Draper, K. G., Gonzalez, C., Jensen, K., Kapeisky, A. M., Modak, A. S., Matulic-Adamic, J., DiRenzo, A. B., Haeberli, P., and Sweeder, D. (1995) Chemical modification of hammerhead ribozymes. J. Biol. Chem. 43, 25,702-25,708.
36. Chu, G., Hayakawa, H., and Berg, P. (1987) Electroporation for the efficient transfection of mammalian cells with DNA. Nucleic Acids Res. 15, 1311-1326.
37. Chen, C. and Okayama, H. (1987) High-efficiency transformation of mammalian cells by plasmid DNA. Mol. Cell. Biol. 7, 2745-2752.
38. Karikó, K., Megyeri, K., Xiao, Q., and Barnathan, E. S. (1994) Lipofectin-aided cell delivery of ribozyme targeted to human urokinase receptor mRNA. FEBS Lett. 352, 41-44.
39. Itani, T., Ariga, H., Yamaguchi, N., Tadakuma, T., and Yasuda, T. (1987) A simple and efficient liposome method for transfection of DNA into mammalian cells grown in suspension. Gene 56, 267-276.
40. Kay, M. A., Holterman, A.-X., Meuse, L., Gown, A., Ochs, H. D., Linsley, P. S., and Wilson, C. B. (1995) Long-term hepatic adenovirus-mediated gene expression in mice following CTLA4Ig administration. Nature Genet. 11, 191-197.
41. Li, M., Lonial, H., Citarella, R., Lindh, D., Colina, L., and Kramer, R. (1996) Tumor inhibitory activity of anti-ras ribozymes delivered by retroviral gene transfer. Cancer Gene Ther. 3, 221-229.
42. Ferrari, F. K., Samulski, T., Shenk, T., and Samulski, R. J. (1996) Second-strand synthesis is a rate-limiting step for efficient transduction by recombinant adeno-associated virus vectors. J. Virol. 70, 3227-3234.
43. Lieber, A. and Kay, M. A. (1996) Adenovirus-mediated expression of ribozymes in mice. J. Virol. 70, 3153-3158.
44. Milligan, J. F., Groebe, D. R., Witherell, G. W., and Uhlenbeck, O. C. (1987) Oligoribonucleotide synthesis using T7 RNA polymerase and synthetic DNA templates. Nucleic Acids Res. 15, 8783-8798.
45. Alam, J. and Cook, J. L. (1990) Reporter genes: application to the study of mammalian gene transcription. Anal. Biochem. 188, 245-254.
46. Homann, M., Tzortzakaki, S., Rittner, K. Sczakiel, G., and Tabler, M. (1993) Incorporation of the catalytic domain of a hammerhead ribozyme into anti sense RNA enhances its inhibitory effect on the replication of human immunodeficiency virus type 1. Nucleic Acids Res. 21, 2809-2814.
47. Kozu, T., Sucoka, E., Okabe, S., Sueoka, N., Komori, A., and Fujiki, H. (1996) Designing of chimeric DNA/RNA hammerhead ribozymes to be targeted against AMLK1/MTG8 mRNA. J. Cancer Res. Clin. Oncol. 122, 254-256.
48. Matsushita, H., Kobayashi, H., Mori, S., Kizaki, M., and Ikeda, Y. (1995) Ribozymes cleave the AML1/ MTG8 fusion transcript and inhibit proliferation of leukemic cells with t(8;21). Biochem. Biophys. Res, Commun. 215, 431-437.
49. Shore, S., Nabissa, P. M., and Reddy, E. P. (1993) Ribozyme-mediated cleavage of the BCRABL oncogene transcript: in vitro cleavage of RNA and in vivo loss of P210 protein-kinase activity. Oncogene 8, 3183-3188.
50. Leopold, L.H., Shore, S.K., Newkirk, T.A., Reddy, R. M. V., and Reddy, E. P. (1995) Multi-unit ribozyme-mediated cleavage of bcr-abl mRNA in myeloid leukemias. Blood 85, 2162-2170.
51. Cantor, G. H., McElwain, T. F., Birkebak, T. A. and Palmer, G. H. (1993) Ribozyme cleaves rex/tax mRNA and inhibits bovine leukemia virus expression. Proc. Natl. Acad. Sci. USA 90, 10,932-10,936.
52. Beck, J. and Nassal, M. (1995) Efficient hammerhead ribozyme-mediated cleavage of the structured hepatitis B virus encapsidation signal in vitro and in cell extracts, but not in intact cells. Nucleic Acids Res. 23, 4954-4962.
53. Offensperger, W.-B., Blum, H. E., and Gerok, W. (1994) Molecular therapeutic strategies in hepatitis B virus infection. Clin. Invest. 72, 737-741.
54. Lu, D., Chatterjee, S., Brar, D. and Wong, K. K., Jr. (1994) Ribozyme-mediated in vitro cleavage of transcripts arising from the major transforming genes of human papillomavirus type 16. Cancer Gene Ther. 1, 267-277.
55. Xing, Z. and Whitton, L. (1993) An anti-lymphocytic choriomeningitis virus ribozyme expressed in tissue culture cells diminishes viral RNA levels and leads to a reduction in infectious virus yield. J. Virol. 67, 1840-1847.
56. Yamada, O., Yu, M., Yee, J.-K., Kraus, G., Looney, D., and Wong-Stall, F. (1994) Intracellular immunization of human T cells with a hairpin ribozyme against human immunodeficiency virus type 1. Gene Ther. 1, 38-45.
57. Feng, M., Cabrera, G., Deshane, J., Scanlon, K. J., and Curiel, D. T. (1995) Neoplastic reversion accomplished by high efficiency adenoviral-mediated delivery of an anti-ras ribozyme. Cancer Res. 55, 2024-2028.